H 2472
An Act protecting patient safety regarding non-FDA approved drugs
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to improve patient safety by regulating the distribution of compounded medications, which are drugs made by pharmacies rather than large pharmaceutical companies and not always approved by the Food and Drug Administration (FDA). The legislation seeks to establish standards and oversight for these medications to reduce potential risks to patients. It focuses on ensuring that compounded drugs are handled safely and effectively.
Key provisions
- Requires compounding pharmacies to adhere to specific quality control standards.
- Mandates reporting of adverse events related to compounded medications.
- Addresses the distribution of compounded medications to ensure patient safety.
- Focuses on medications not approved by the FDA.
- Establishes a process for reviewing compounded medication practices.
- Requires pharmacies to maintain records related to compounded medications.
- Promotes transparency in the compounding process.
Who is affected
- Compounding pharmacies
- Patients receiving compounded medications
- Healthcare providers prescribing compounded medications
- The public
- The pharmaceutical industry
Notable changes
- Increases oversight of compounded medications.
- Addresses potential safety concerns associated with non-FDA approved drugs.
- Requires pharmacies to implement stricter quality control measures.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Kathleen R. LaNatra
Cosponsors
Kathleen R. LaNatra
Patrick Joseph Kearney
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.2472 194th (Current)
An Act protecting patient safety regarding non-FDA approved drugs
By Representative LaNatra of Kingston, a petition (accompanied by bill, House, No. 2472) of Kathleen R. LaNatra and Patrick Joseph Kearney relative to the distribution of compounded medications. Public Health.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Kathleen R. LaNatra
Tabs
Bill History Petitioners Committee Vote Committee Summary
Bill History
Displaying 5 actions for Bill H.2472
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Public Health |
| 2/27/2025 | Senate | Senate concurred |
| 6/10/2025 | Joint | Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1 |
| 9/11/2025 | House | Reporting date extended to Thursday, October 9, 2025 |
| 3/16/2026 | House | Accompanied a study order, see H5234 |
Similar Bills
H.2463 194th (Current)
An Act relative to proper classification of health care workers during a public health emergency
H.3717 194th (Current)
An Act to modernize and enhance the distribution of Chapter 90 funds
H.1701 194th (Current)
An Act relative to drug distribution causing death
H.996 194th (Current)
An Act relative to helium balloons
H.2252 194th (Current)
An Act to establish a commission to study the distribution of unrestricted local aid
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.